• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009 年流感大流行期间日本采集的甲型 H1N1 病毒的突变分析。

Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic.

机构信息

Omics Science Center, RIKEN Yokohama Institute, Yokohama, Japan.

出版信息

PLoS One. 2011 Apr 29;6(4):e18956. doi: 10.1371/journal.pone.0018956.

DOI:10.1371/journal.pone.0018956
PMID:21572517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3084724/
Abstract

BACKGROUND

Pandemic influenza A(H1N1) virus infection quickly circulated worldwide in 2009. In Japan, the first case was reported in May 2009, one month after its outbreak in Mexico. Thereafter, A(H1N1) infection spread widely throughout the country. It is of great importance to profile and understand the situation regarding viral mutations and their circulation in Japan to accumulate a knowledge base and to prepare clinical response platforms before a second pandemic (pdm) wave emerges.

METHODOLOGY

A total of 253 swab samples were collected from patients with influenza-like illness in the Osaka, Tokyo, and Chiba areas both in May 2009 and between October 2009 and January 2010. We analyzed partial sequences of the hemagglutinin (HA) and neuraminidase (NA) genes of the 2009 pdm influenza virus in the collected clinical samples. By phylogenetic analysis, we identified major variants of the 2009 pdm influenza virus and critical mutations associated with severe cases, including drug-resistance mutations.

RESULTS AND CONCLUSIONS

Our sequence analysis has revealed that both HA-S220T and NA-N248D are major non-synonymous mutations that clearly discriminate the 2009 pdm influenza viruses identified in the very early phase (May 2009) from those found in the peak phase (October 2009 to January 2010) in Japan. By phylogenetic analysis, we found 14 micro-clades within the viruses collected during the peak phase. Among them, 12 were new micro-clades, while two were previously reported. Oseltamivir resistance-related mutations, i.e., NA-H275Y and NA-N295S, were also detected in sporadic cases in Osaka and Tokyo.

摘要

背景

甲型 H1N1 流感病毒于 2009 年在全球迅速传播。在日本,首例病例于 2009 年 5 月报告,比墨西哥首例病例晚一个月。此后,A(H1N1)感染在全国范围内广泛传播。了解病毒突变及其在日本的传播情况并积累知识库,以及在第二次大流行(pdm)浪潮出现之前准备临床应对平台,这一点非常重要。

方法

共收集了 2009 年 5 月和 2009 年 10 月至 2010 年 1 月期间在大阪、东京和千叶地区流感样疾病患者的 253 个拭子样本。我们分析了收集的临床样本中 2009 年 pdm 流感病毒血凝素(HA)和神经氨酸酶(NA)基因的部分序列。通过系统进化分析,我们确定了 2009 年 pdm 流感病毒的主要变异株和与重症病例相关的关键突变,包括耐药性突变。

结果与结论

我们的序列分析表明,HA-S220T 和 NA-N248D 都是主要的非同义突变,可明确区分 2009 年 pdm 流感病毒在日本早期(2009 年 5 月)和高峰期(2009 年 10 月至 2010 年 1 月)鉴定的病毒。通过系统进化分析,我们发现高峰期采集的病毒中有 14 个微进化枝。其中,12 个是新的微进化枝,而 2 个是之前报道过的。在大阪和东京的散发病例中也检测到奥司他韦耐药相关突变,即 NA-H275Y 和 NA-N295S。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/d70a54cac3be/pone.0018956.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/4ccff1165d6d/pone.0018956.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/0539990e3a89/pone.0018956.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/4fd4aecfc604/pone.0018956.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/0e10a4f039b0/pone.0018956.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/d70a54cac3be/pone.0018956.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/4ccff1165d6d/pone.0018956.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/0539990e3a89/pone.0018956.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/4fd4aecfc604/pone.0018956.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/0e10a4f039b0/pone.0018956.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/3084724/d70a54cac3be/pone.0018956.g005.jpg

相似文献

1
Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic.2009 年流感大流行期间日本采集的甲型 H1N1 病毒的突变分析。
PLoS One. 2011 Apr 29;6(4):e18956. doi: 10.1371/journal.pone.0018956.
2
Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon.黎巴嫩大流行 H1N1 2009 的遗传多样性和抗病毒药物耐药性。
J Clin Virol. 2011 Jul;51(3):170-4. doi: 10.1016/j.jcv.2011.04.001. Epub 2011 May 11.
3
Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.日本大流行及大流行后期四个季节中分离的耐神经氨酸酶抑制剂的甲型 H1N1pdm09 流感病毒的特征。
Influenza Other Respir Viruses. 2013 Nov;7(6):1390-9. doi: 10.1111/irv.12132. Epub 2013 Jun 8.
4
Genetic sequencing of influenza A (H1N1) pdm09 isolates from South India, collected between 2011 and 2015 to detect mutations affecting virulence and resistance to oseltamivir.对 2011 年至 2015 年间在印度南部采集的甲型流感(H1N1)pdm09 分离株进行基因测序,以检测影响病毒毒力和对奥司他韦耐药性的突变。
Indian J Med Microbiol. 2020 Jul-Dec;38(3 & 4):324-337. doi: 10.4103/ijmm.IJMM_20_83.
5
Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.抗金刚烷胺和奥司他韦耐药的人甲型 H1N1 流感病毒的遗传构成。
J Clin Microbiol. 2010 Apr;48(4):1085-92. doi: 10.1128/JCM.01532-09. Epub 2010 Feb 3.
6
Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.台湾地区发现对奥司他韦耐药的大流行(H1N1)2009 流感 A 病毒的早期结果。
Antiviral Res. 2010 Dec;88(3):256-62. doi: 10.1016/j.antiviral.2010.09.014. Epub 2010 Sep 24.
7
[Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai].上海儿童新型甲型H1N1流感感染的临床特征与分子流行病学研究
Zhonghua Er Ke Za Zhi. 2013 May;51(5):356-61.
8
Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.西班牙的耐奥司他韦的大流行性流感 A(H1N1)2009 病毒。
J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.
9
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.日本 2008-2009 年季节性流感期间出现 H274Y 耐药的奥司他韦抗甲型 H1N1 流感病毒。
J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.
10
Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.基因特征表明,2005 年至 2009 年期间,印度东部出现了对奥司他韦耐药的 H1N1 流感病毒。
Infect Genet Evol. 2010 Dec;10(8):1188-98. doi: 10.1016/j.meegid.2010.07.019. Epub 2010 Aug 1.

引用本文的文献

1
Evolution of Indian Influenza A (H1N1) Hemagglutinin Strains: A Comparative Analysis of the Pandemic Californian HA Strain.印度甲型流感(H1N1)血凝素毒株的演变:与大流行的加利福尼亚HA毒株的比较分析
Front Mol Biosci. 2023 Mar 16;10:1111869. doi: 10.3389/fmolb.2023.1111869. eCollection 2023.
2
Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.2009 年甲型 H1N1 流感病毒在志愿者人体挑战研究参与者和自然感染中的深度测序。
Virology. 2019 Aug;534:96-107. doi: 10.1016/j.virol.2019.06.004. Epub 2019 Jun 13.
3
Intra-host and intra-household diversity of influenza A viruses during household transmissions in the 2013 season in 2 peri-urban communities of South Africa.

本文引用的文献

1
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.奥司他韦耐药 2009 年 H1N1 大流行流感 A 病毒的特征。
PLoS Pathog. 2010 Aug 26;6(8):e1001079. doi: 10.1371/journal.ppat.1001079.
2
Molecular evolutionary analysis of the influenza A(H1N1)pdm, May-September, 2009: temporal and spatial spreading profile of the viruses in Japan.2009 年 5 月至 9 月甲型 H1N1 流感的分子进化分析:日本病毒的时间和空间传播特征。
PLoS One. 2010 Jun 10;5(6):e11057. doi: 10.1371/journal.pone.0011057.
3
Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine.
2013 年南非两个城郊社区中家庭传播期间甲型流感病毒的宿主内和家庭内多样性。
PLoS One. 2018 May 24;13(5):e0198101. doi: 10.1371/journal.pone.0198101. eCollection 2018.
4
Phylogenetic Exploration of Nosocomial Transmission Chains of 2009 Influenza A/H1N1 among Children Admitted at Red Cross War Memorial Children's Hospital, Cape Town, South Africa in 2011.2011年南非开普敦红十字战争纪念儿童医院收治儿童中2009年甲型H1N1流感医院传播链的系统发育探索
PLoS One. 2015 Nov 13;10(11):e0141744. doi: 10.1371/journal.pone.0141744. eCollection 2015.
5
Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.2012年流感季节阿根廷的流感病毒监测:抗原特性、基因分析及抗病毒敏感性
Epidemiol Infect. 2016 Mar;144(4):751-67. doi: 10.1017/S0950268815001806. Epub 2015 Sep 8.
6
Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design.灵芝三萜对神经氨酸酶的抑制作用及其对神经氨酸酶抑制剂设计的启示。
Sci Rep. 2015 Aug 26;5:13194. doi: 10.1038/srep13194.
7
Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.甲型H1N1流感病毒在英国人群中传播期间人类适应性突变的积累
J Virol. 2014 Nov;88(22):13269-83. doi: 10.1128/JVI.01636-14. Epub 2014 Sep 10.
8
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.2012 - 2013年全球人类流感病毒对神经氨酸酶抑制剂敏感性的最新情况
Antiviral Res. 2014 Oct;110:31-41. doi: 10.1016/j.antiviral.2014.07.001. Epub 2014 Jul 17.
9
Pathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaques.免疫功能低下食蟹猴感染大流行 H1N1 流感病毒的致病性。
PLoS One. 2013 Sep 23;8(9):e75910. doi: 10.1371/journal.pone.0075910. eCollection 2013.
10
Molecular evolution of the hemagglutinin and neuraminidase genes of pandemic (H1N1) 2009 influenza viruses in Sendai, Japan, during 2009-2011.2009 - 2011年期间日本仙台大流行(H1N1)2009流感病毒血凝素和神经氨酸酶基因的分子进化
Virus Genes. 2013 Sep 29;47(3):456-66. doi: 10.1007/s11262-013-0980-5.
更新:流感活动 - 美国,2009 年 8 月 30 日至 2010 年 3 月 27 日,以及 2010-11 年流感疫苗的组成。
MMWR Morb Mortal Wkly Rep. 2010 Apr 16;59(14):423-30.
4
Structures of influenza A proteins and insights into antiviral drug targets.甲型流感病毒蛋白结构及其抗病毒药物靶点的研究进展
Nat Struct Mol Biol. 2010 May;17(5):530-8. doi: 10.1038/nsmb.1779. Epub 2010 Apr 11.
5
Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin.甲型H1N1流感大流行病毒血凝素的结构与受体结合特性
PLoS Curr. 2010 Mar 22;2:RRN1152. doi: 10.1371/currents.RRN1152.
6
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.对 2009 年 H1N1 大流行流感病毒预先存在免疫的结构基础。
Science. 2010 Apr 16;328(5976):357-60. doi: 10.1126/science.1186430. Epub 2010 Mar 25.
7
Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus.大流行(H1N1)2009 流感 A 病毒的基因组特征和突变趋势分析。
PLoS One. 2010 Mar 8;5(3):e9549. doi: 10.1371/journal.pone.0009549.
8
Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010.2009-2010 年挪威观察到 2009 年大流行性流感 A(H1N1)病毒 HA1 突变 D222G 与严重临床结局之间的关联。
Euro Surveill. 2010 Mar 4;15(9):19498. doi: 10.2807/ese.15.09.19498-en.
9
A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.日本山形县奥司他韦耐药性甲型 H1N1 流感病毒的两年监测及奥司他韦和扎那米韦的临床疗效。
Virol J. 2010 Mar 5;7:53. doi: 10.1186/1743-422X-7-53.
10
The early diversification of influenza A/H1N1pdm.甲型H1N1流感大流行病毒的早期多样化
PLoS Curr. 2009 Nov 3;1:RRN1126. doi: 10.1371/currents.rrn1126.